452 related articles for article (PubMed ID: 16254192)
1. CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50.
Paz-Priel I; Cai DH; Wang D; Kowalski J; Blackford A; Liu H; Heckman CA; Gombart AF; Koeffler HP; Boxer LM; Friedman AD
Mol Cancer Res; 2005 Oct; 3(10):585-96. PubMed ID: 16254192
[TBL] [Abstract][Full Text] [Related]
2. C/EBPα, C/EBPα oncoproteins, or C/EBPβ preferentially bind NF-κB p50 compared with p65, focusing therapeutic targeting on the C/EBP:p50 interaction.
Dooher JE; Paz-Priel I; Houng S; Baldwin AS; Friedman AD
Mol Cancer Res; 2011 Oct; 9(10):1395-405. PubMed ID: 21813505
[TBL] [Abstract][Full Text] [Related]
3. Establishment of the acute myeloid leukemia cell line Kasumi-6 from a patient with a dominant-negative mutation in the DNA-binding region of the C/EBPalpha gene.
Asou H; Gombart AF; Takeuchi S; Tanaka H; Tanioka M; Matsui H; Kimura A; Inaba T; Koeffler HP
Genes Chromosomes Cancer; 2003 Feb; 36(2):167-74. PubMed ID: 12508245
[TBL] [Abstract][Full Text] [Related]
4. Elevated c-Jun expression in acute myeloid leukemias inhibits C/EBPalpha DNA binding via leucine zipper domain interaction.
Rangatia J; Vangala RK; Singh SM; Peer Zada AA; Elsässer A; Kohlmann A; Haferlach T; Tenen DG; Hiddemann W; Behre G
Oncogene; 2003 Jul; 22(30):4760-4. PubMed ID: 12879022
[TBL] [Abstract][Full Text] [Related]
5. AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia.
Pabst T; Mueller BU; Harakawa N; Schoch C; Haferlach T; Behre G; Hiddemann W; Zhang DE; Tenen DG
Nat Med; 2001 Apr; 7(4):444-51. PubMed ID: 11283671
[TBL] [Abstract][Full Text] [Related]
6. C/EBPalpha or C/EBPalpha oncoproteins regulate the intrinsic and extrinsic apoptotic pathways by direct interaction with NF-kappaB p50 bound to the bcl-2 and FLIP gene promoters.
Paz-Priel I; Ghosal AK; Kowalski J; Friedman AD
Leukemia; 2009 Feb; 23(2):365-74. PubMed ID: 18987666
[TBL] [Abstract][Full Text] [Related]
7. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia.
Pabst T; Mueller BU; Zhang P; Radomska HS; Narravula S; Schnittger S; Behre G; Hiddemann W; Tenen DG
Nat Genet; 2001 Mar; 27(3):263-70. PubMed ID: 11242107
[TBL] [Abstract][Full Text] [Related]
8. C/EBPα and C/EBPα oncoproteins regulate nfkb1 and displace histone deacetylases from NF-κB p50 homodimers to induce NF-κB target genes.
Paz-Priel I; Houng S; Dooher J; Friedman AD
Blood; 2011 Apr; 117(15):4085-94. PubMed ID: 21346255
[TBL] [Abstract][Full Text] [Related]
9. The tumour necrosis factor-alpha-mediated suppression of the CCAAT/enhancer binding protein-alpha gene transcription in hepatocytes involves inhibition of autoregulation.
Foka P; Singh NN; Salter RC; Ramji DP
Int J Biochem Cell Biol; 2009 May; 41(5):1189-97. PubMed ID: 19027873
[TBL] [Abstract][Full Text] [Related]
10. C/EBPalphap30, a myeloid leukemia oncoprotein, limits G-CSF receptor expression but not terminal granulopoiesis via site-selective inhibition of C/EBP DNA binding.
Cleaves R; Wang QF; Friedman AD
Oncogene; 2004 Jan; 23(3):716-25. PubMed ID: 14737106
[TBL] [Abstract][Full Text] [Related]
11. BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2.
Perrotti D; Cesi V; Trotta R; Guerzoni C; Santilli G; Campbell K; Iervolino A; Condorelli F; Gambacorti-Passerini C; Caligiuri MA; Calabretta B
Nat Genet; 2002 Jan; 30(1):48-58. PubMed ID: 11753385
[TBL] [Abstract][Full Text] [Related]
12. Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma.
Thornburg NJ; Pathmanathan R; Raab-Traub N
Cancer Res; 2003 Dec; 63(23):8293-301. PubMed ID: 14678988
[TBL] [Abstract][Full Text] [Related]
13. CCAAT/enhancer binding protein alpha knock-in mice exhibit early liver glycogen storage and reduced susceptibility to hepatocellular carcinoma.
Tan EH; Hooi SC; Laban M; Wong E; Ponniah S; Wee A; Wang ND
Cancer Res; 2005 Nov; 65(22):10330-7. PubMed ID: 16288022
[TBL] [Abstract][Full Text] [Related]
14. C/EBPα in normal and malignant myelopoiesis.
Friedman AD
Int J Hematol; 2015 Apr; 101(4):330-41. PubMed ID: 25753223
[TBL] [Abstract][Full Text] [Related]
15. Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice.
Ryu H; Smith K; Camelo SI; Carreras I; Lee J; Iglesias AH; Dangond F; Cormier KA; Cudkowicz ME; Brown RH; Ferrante RJ
J Neurochem; 2005 Jun; 93(5):1087-98. PubMed ID: 15934930
[TBL] [Abstract][Full Text] [Related]
16. Diminished expression of C/EBPalpha in skin carcinomas is linked to oncogenic Ras and reexpression of C/EBPalpha in carcinoma cells inhibits proliferation.
Shim M; Powers KL; Ewing SJ; Zhu S; Smart RC
Cancer Res; 2005 Feb; 65(3):861-7. PubMed ID: 15705884
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of human osteopontin promoter by C/EBPalpha and AML-1 in metastatic cancer cells.
Liu YN; Kang BB; Chen JH
Oncogene; 2004 Jan; 23(1):278-88. PubMed ID: 14712233
[TBL] [Abstract][Full Text] [Related]
18. NF-kappa B p50 regulates C/EBP alpha expression and inflammatory cytokine-induced neutrophil production.
Wang D; Paz-Priel I; Friedman AD
J Immunol; 2009 May; 182(9):5757-62. PubMed ID: 19380823
[TBL] [Abstract][Full Text] [Related]
19. Amino acid residues in the beta3 strand and subsequent loop of the conserved ETS domain that mediate basic leucine zipper (bZIP) recruitment and potentially distinguish functional attributes of Ets proteins.
Shimokawa T; Nunomura S; Enomoto Y; Ra C
Biochem J; 2010 Aug; 430(1):129-39. PubMed ID: 20522024
[TBL] [Abstract][Full Text] [Related]
20. Cell cycle inhibition mediated by the outer surface of the C/EBPalpha basic region is required but not sufficient for granulopoiesis.
Wang QF; Cleaves R; Kummalue T; Nerlov C; Friedman AD
Oncogene; 2003 May; 22(17):2548-57. PubMed ID: 12730669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
